Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs

Aplastic anemia (AA) is characterized as hypoplasia of bone marrow hematopoietic cells and hematopenia of peripheral blood cells. Though the supplement of exogenous erythropoietin (EPO) has been clinically approved for AA treatment, the side-effects hinder its further application. Here a robust trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Wang, Zhen, Mingming, Li, Lei, Zhou, Chen, Sun, Zihao, Liu, Shuai, Zhao, Zhongpu, Li, Jie, Wang, Chunru, Bai, Chunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295067/
https://www.ncbi.nlm.nih.gov/pubmed/32550910
http://dx.doi.org/10.7150/thno.46794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295067/
https://www.ncbi.nlm.nih.gov/pubmed/32550910
http://dx.doi.org/10.7150/thno.46794

Ejemplares similares